Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Bernard F. Germain"'
Autor:
Mitchel J. Seleznick, Mitchell Lowenstein, Keith S. Kanik, Frank B. Vases, Bernard F. Germain, Luis R. Espinosa, Paul H. Bridgefor, Joann Valeriano-Marcet
Publikováno v:
JCR: Journal of Clinical Rheumatology. 3:319-323
Polymyalgia rheumatica (PMR) is an inflammatory disorder characterized by severe proximal myalgias associated with an elevated erythrocyte sedimentation rate (ESR). In this report 10 otherwise typical PMR patients with an ESR35 mm/hr, and 10 PMR pati
Autor:
Bernard F. Germain, Dennis Torretti, Larry J. Anderson, Herbert Kaplan, Sheldon D. Solomon, Barbara N. Weissman, Frederick Wolfe, Eric P. Gall, Michael E. Weinblatt, Richard C. Merriman, Sidney R. Block, Bruce Wall
Publikováno v:
Arthritis & Rheumatism. 37:1492-1498
Objective. To evaluate the efficacy and tolerability of oral methotrexate (MTX) in rheumatoid arthritis (RA) in a long-term prospective trial. Methods. One hundred twenty-three patients with RA who completed a 9-month multicenter randomized trial com
Autor:
Bernard F. Germain, Jonathan S. Coblyn, Bruce Wall, Michael H. Weisman, Agnes L. Maier, Michael E. Weinblatt, Joel M. Kremer
Publikováno v:
Arthritis & Rheumatism. 37:1321-1325
Objective. To assess whether the synthetic prostaglandin misoprostol is renal protective in rheumatoid arthritis (RA) patients who are beginning cyclosporin A (CSA) therapy. Methods. In this randomized, placebo–controlled, multicenter trial, 50 pat
Autor:
Luis J. Jara, Luis H. Silveira, Pindaro Martinez-Osuna, Bernard F. Germain, Carlos Lavalle, Luis R. Espinoza, Antonio Fraga, Celso E. Gomez-Sanchez
Publikováno v:
Seminars in Arthritis and Rheumatism. 20:273-284
Cells of the immune system synthesize prolactin and express mRNA and receptors for that hormone. Interleukin 1, interleukin 6, gamma interferon, tumor necrosis factor, platelet activator factor, and substance P participate in the release of prolactin
Autor:
Richard P. Polisson, Frederick Wolfe, Eric P. Gall, Michael E. Weinblatt, Bruce Wall, Ralph E. Small, Sidney R. Block, Dennis Torretti, Robert Irby, Richard C. Merriman, Jon Coblyn, Sheldon D. Solomon, Joseph J. Biundo, Herbert Kaplan, Bernard F. Germain, Larry J. Anderson
Publikováno v:
Arthritis & Rheumatism. 33:330-338
Weekly treatment with low-dose oral methotrexate (MTX) was compared with daily auranofin (AUR) treatment in a 36-week double-blind, randomized, multicenter study of 281 patients with active, adult-onset rheumatoid arthritis. Both treatment groups sho
Autor:
William E. Evans, Mitchel J. Seleznick, Ronald A. Fleming, Clinton F. Stewart, Bernard F. Germain
Publikováno v:
Arthritis and rheumatism. 34(12)
Intravenous methotrexate (MTX) (10 mg), either alone or with oral aspirin (ASA) (3,900 mg/day), was administered to 15 patients with rheumatoid arthritis. Systemic and renal clearance of MTX were lower, and the unbound fraction of MTX was higher when
Autor:
David Y. Graham, Bernard F. Germain, Richard H. White, Jeffry A. Brown, Sanford H. Roth, Naurang M. Agrawal, Scott C. Stromatt
Publikováno v:
Clinical Journal of Sport Medicine. 2:74-75
Objectives To compare the efficacy and frequency of adverse experiences of misoprostol and sucralfate in the prevention of gastric ulcers in patients receiving nonsteroidal anti-inflammatory drug (NSAID) therapy. Design A prospective, randomized, sin
Publikováno v:
Advances in Pediatrics. 26:93-118
Autor:
Allen D. Meisel, Bernard F. Germain
Publikováno v:
Seminars in Arthritis and Rheumatism. 14:7-10
The efficacy of piroxicam 20 mg/qd was compared with that of sulindac 200 mg twice a day in 49 patients with rheumatoid arthritis. Both nonsteroidal anti-inflammatory agents showed statistically significant improvement in efficacy variables including
Autor:
Mark H. Cohen, Bernard F. Germain, Sanford S. Hartman, Sanford Baim, Bernard J. Mullen, Adrian Jaffer, Daniel J. Appelrouth, De Witt W. Englund, Rowland W. Chang, Fredrica E. Smith
Publikováno v:
The American Journal of Medicine. 83:78-81
A six-month, multicenter, double-blind study compared the efficacy and safety of two therapeutic regimens in 332 patients with osteoarthritis. The patients received either 1,000 mg of nabumetone as a single bedtime dose or 900 mg of aspirin in four d